Review
Published on 15 Jun 2023
Mitochondrial homeostasis: a potential target for delaying renal aging
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1191517
- 2,963 views
- 6 citations
Type at least 3 characters
591 articles
Articles
Original Research
Published on 13 Jun 2023
The macrocyclic lactone oxacyclododecindione reduces fibrosis progression
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1200164
- 2,210 views
- 2 citations
Correction
Published on 09 Jun 2023
Corrigendum: Phyllanthus niruri L. exerts protective effects against the calcium oxalate-induced renal injury via ellgic acid
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1207268
- 1,147 views
Original Research
Published on 08 Jun 2023
Molecular mechanism of Hedyotis Diffusae Herba in the treatment of lupus nephritis based on network pharmacology
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1118804
- 1,940 views
- 2 citations
Original Research
Published on 08 Jun 2023
The role of the SGK3/TOPK signaling pathway in the transition from acute kidney injury to chronic kidney disease
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1169054
- 4,745 views
- 3 citations
Opinion
Published on 06 Jun 2023
Dysfunction of von-Hippel Lindau factor causes reduced degradation of HIF leading to renal cancer. Hypoxia-inducible factor-prolyl hydroxylase enzyme inhibitors also lessen HIF destruction and could therefore increase renal cancer
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1170796
- 1,363 views
- 3 citations
General Commentary
Published on 30 May 2023
Commentary: Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1214664
- 2,086 views
Original Research
Published on 25 May 2023
APOC1 exacerbates renal fibrosis through the activation of the NF-ÎşB signaling pathway in IgAN
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1181435
- 4,765 views
- 2 citations
Systematic Review
Published on 24 May 2023
Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1163908
- 6,484 views
- 8 citations
Review
Published on 23 May 2023
A comprehensive review of acute cardio-renal syndrome: need for novel biomarkers
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1152055
- 10,246 views
- 7 citations
Original Research
Published on 18 May 2023
In silico evidence implicating novel mechanisms of Prunella vulgaris L. as a potential botanical drug against COVID-19-associated acute kidney injury
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1188086
- 2,718 views
- 3 citations
Original Research
Published on 18 May 2023
Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1189608
- 1,958 views
- 2 citations
Original Research
Published on 17 May 2023
Therapeutic mechanism of baicalein in peritoneal dialysis-associated peritoneal fibrosis based on network pharmacology and experimental validation
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1153503
- 2,797 views
- 2 citations
Original Research
Published on 16 May 2023
Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1172269
- 2,278 views
- 7 citations
Original Research
Published on 15 May 2023
Olmesartan alleviates SARS-CoV-2 envelope protein induced renal fibrosis by regulating HMGB1 release and autophagic degradation of TGF-β1
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1187818
- 2,130 views
- 9 citations
Original Research
Published on 11 May 2023
Canagliflozin alleviates high glucose-induced peritoneal fibrosis via HIF-1α inhibition
in Renal Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1152611
- 3,165 views
- 7 citations